US 11618733
Crystalline salts of a plasma kallikrein inhibitor
granted A61KA61K9/0019A61K9/0029
Quick answer
US patent 11618733 (Crystalline salts of a plasma kallikrein inhibitor) held by BioCryst Pharmaceuticals, Inc. expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K9/0019, A61K9/0029, A61K9/0053, A61P